U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07668934) titled 'TAF in Early/Middle Pregnancy With CHB' on April 09.
Brief Summary: The goal of this clinical trial is to study the efficacy and safety of Tenofovir alafenamide (TAF) vs Tenofovir disoproxil fumarate(TDF) in early and middle pregnancy with chronic hepatitis B.
Study Start Date: March 31, 2025
Study Type: INTERVENTIONAL
Condition:
Hepatitis B Infection
Pregnant Women
Early Pregnancy
Intervention:
DRUG: TAF
Taking TAF from early or middle pregnancy
DRUG: TDF
Taking TDF from early or middle pregnancy
Recruitment Status: ENROLLING_BY_INVITATION
Sponsor: The Third Affiliated Hospital of Guangzhou Medical University
Published ...